Skip to content

PI PHARMA: what changed

BE 0883.315.652NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€174,639
2024 · €26,306+€148,333
Equity
-€161,750
2024 · -€336,389+€174,639
Cash
€349,739
2024 · €1.2m-€892,633
Balance sheet total
€13.2m
2024 · €4.8m+€8.4m

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€9.5m

    up €9.5m (+301%), from €3.2m to €12.6m

    of which Trade receivables: +€9.5m

  • Cash -€892,633

    down €892,633 (-71.8%), from €1.2m to €349,739

    mainly Receivables within one year (-€9.5m)

Equity and liabilities
  • Trade debts +€5.0m

    up €5.0m (+155%), from €3.2m to €8.2m

  • Other debts +€1.9m

    first reported in 2025, at €1.9m

  • Tax, wage and social debts +€1.3m

    up €1.3m (+68.0%), from €1.9m to €3.2m

    of which Taxes: +€1.3m

  • Profit (loss) carried forward +€174,639

    up €174,639 (+13.6%), from -€1.3m to -€1.1m

Income statement
  • Turnover +€16.3m

    up €16.3m (+40.7%), from €40.1m to €56.4m

  • Goods and materials +€14.7m

    up €14.7m (+41.5%), from €35.4m to €50.1m

    of which Purchases: +€14.5m

  • Other operating charges +€788,047

    up €788,047 (+62.2%), from €1.3m to €2.1m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €26,306
Turnover +€16.3m
Other operating income -€25,272
Goods and materials -€14.7m
Services and other goods -€168,243
Staff costs -€27,909
Depreciation +€18,849
Other operating charges -€788,047
Other operating items -€475,286
Financial income +€21,109
Financial charges +€14,535
Taxes -€39,799
Result 2025 €174,639
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€921,780
Investment +€29,147
Financing €0
Cash 2024 €1.2m
Net result for the year +€174,639
Depreciation +€47,849
Stocks and contracts +€100,345
Receivables within one year -€9.5m
Deferred charges and accrued income +€35,515
Trade debts +€5.0m
Tax, wage and social debts +€1.3m
Other debts +€1.9m
Investment in fixed assets (net) +€29,147
Cash 2025 €349,739
brings cash intakes cash out
Every line side by side 59 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,815,498 €13,202,253 +€8.4m +174%
Fixed assets 21/28 €152,331 €75,335 -€76,996 -50.5%
Intangible fixed assets 21 €129,324 €39,584 -€89,740 -69.4%
Tangible fixed assets 22/27 €23,007 €35,751 +€12,744 +55.4%
Plant, machinery and equipment 23 €23,007 €35,751 +€12,744 +55.4%
Current assets 29/58 €4,663,168 €13,126,918 +€8.5m +182%
Stocks and contracts in progress 3 €227,303 €126,958 -€100,345 -44.1%
Stocks 30/36 €227,303 €126,958 -€100,345 -44.1%
Raw materials and consumables 30/31 €194,534 €74,600 -€119,934 -61.7%
Goods purchased for resale 34 €32,769 €52,358 +€19,589 +59.8%
Amounts receivable within one year 40/41 €3,152,117 €12,644,361 +€9.5m +301%
Trade receivables 40 €3,096,415 €12,644,361 +€9.5m +308%
Other amounts receivable 41 €55,702 - -€55,702
Cash at bank and in hand 54/58 €1,242,372 €349,739 -€892,633 -71.8%
Deferred charges and accrued income 490/1 €41,375 €5,860 -€35,515 -85.8%
Total equity and liabilities 10/49 €4,815,498 €13,202,253 +€8.4m +174%
Equity 10/15 -€336,389 -€161,750 +€174,639 +51.9%
Contributions 10/11 €862,500 €862,500 = 0.0%
Capital 10 €862,500 €862,500 = 0.0%
Issued capital 100 €862,500 €862,500 = 0.0%
Reserves 13 €86,250 €86,250 = 0.0%
Non-distributable reserves 130/1 €86,250 €86,250 = 0.0%
Legal reserve 130 €86,250 €86,250 = 0.0%
Profit (loss) carried forward 14 -€1,285,139 -€1,110,500 +€174,639 +13.6%
Amounts payable 17/49 €5,151,887 €13,364,002 +€8.2m +159%
Amounts payable within one year 42/48 €5,151,887 €13,364,002 +€8.2m +159%
Trade debts 44 €3,219,752 €8,209,193 +€5.0m +155%
Suppliers 440/4 €3,219,752 €8,209,193 +€5.0m +155%
Taxes, remuneration and social security 45 €1,932,135 €3,246,078 +€1.3m +68.0%
Taxes 450/3 €1,781,455 €3,080,261 +€1.3m +72.9%
Remuneration and social security 454/9 €150,679 €165,817 +€15,137 +10.0%
Other amounts payable 47/48 - €1,908,731 +€1.9m
Operating income 70/76A €40,621,451 €56,915,642 +€16.3m +40.1%
Turnover 70 €40,057,635 €56,377,098 +€16.3m +40.7%
Other operating income 74 €563,816 €538,545 -€25,272 -4.5%
Operating charges 60/66A €40,281,464 €56,423,167 +€16.1m +40.1%
Goods for resale, raw materials and consumables 60 €35,447,989 €50,149,056 +€14.7m +41.5%
Purchases 600/8 €35,587,920 €50,048,711 +€14.5m +40.6%
Change in stocks: decrease (increase) 609 -€139,931 €100,345 +€240,276
Services and other goods 61 €2,250,017 €2,418,260 +€168,243 +7.5%
Remuneration, social security and pensions 62 €1,223,533 €1,251,442 +€27,909 +2.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €66,698 €47,849 -€18,849 -28.3%
Other operating charges 640/8 €1,267,135 €2,055,182 +€788,047 +62.2%
Non-recurring operating charges 66A €26,092 €501,378 +€475,286 +1,822%
Operating profit (loss) 9901 €339,987 €492,475 +€152,488 +44.9%
Financial income 75/76B €255 €21,364 +€21,109 +8,291%
Recurring financial income 75 €255 €21,364 +€21,109 +8,291%
Income from current assets 751 - €21,323 +€21,323
Other financial income 752/9 €255 €41 -€214 -84.0%
Financial charges 65/66B €279,116 €264,581 -€14,535 -5.2%
Recurring financial charges 65 €279,116 €264,581 -€14,535 -5.2%
Debt charges 650 €229,820 €184,433 -€45,387 -19.7%
Other financial charges 652/9 €49,297 €80,148 +€30,852 +62.6%
Profit (loss) for the period before taxes 9903 €61,125 €249,258 +€188,133 +308%
Income taxes 67/77 €34,820 €74,619 +€39,799 +114%
Taxes 670/3 €36,000 €80,000 +€44,000 +122%
Tax adjustments and reversals of tax provisions 77 €1,180 €5,381 +€4,201 +356%
Profit (loss) for the period 9904 €26,306 €174,639 +€148,333 +564%
Profit (loss) for the period to be appropriated 9905 €26,306 €174,639 +€148,333 +564%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€933,069 to €1.3m

Midpoint €1.1m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity -€201,333
Capitalised earnings €2.1m to €2.9m
Indication €933,069 to €1.3m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€161,750
Intangible fixed assets (21)
-€39,584
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€201,333

Capitalised earnings

net result for the year (9904)
2025
€174,639
excluding non-recurring income and charges
€676,018
2024
€26,306
excluding non-recurring income and charges
€52,398
2023
€125,470
excluding non-recurring income and charges
€139,922
2022
-€84,523
excluding non-recurring income and charges
-€85,152
2021
-€1,729,094
excluding non-recurring income and charges
-€1,728,104
Average result, excluding non-recurring income and charges
€289,446
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2.1m / €2.4m / €2.9m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.